Nicaraven, a hydroxyl radical-specific scavenger has been demonstrated to attenuate radiation injury in hematopoietic stem cells with 5 Gy γ-ray exposures. We explored the effect and related mechanisms of nicaraven for protecting radiation injury induced by sequential exposures to a relatively lower dose γ-ray. C57BL/6 mice were given nicaraven or placebo within 30 minutes before exposure to 50 mGy γ-ray daily for 30 days in sequences (cumulative dose of 1.5 Gy). Mice were victimized 24 hours after the last radiation exposure, and the number, function and oxidative stress of hematopoietic stem cells were quantitatively estimated. We also compared the gene expression in these 
Introduction
Acute exposure to ionizing radiation at a dose range of 0.7 to 4 Gy is well defined to develop symptoms associated with hematopoietic and immune damages [1] . It has also reported the increased incidence of cancer risk in nuclear workers who classically exposed to low doses of extraordinary rates [2] . Furthermore, medical doctors and technicians have been shown high incidence of chromosomal disruptions and hematopoietic malignancies even if with exposure to less than 50 mGy [3] [4] [5] . Although many chemical and biological compounds were widely tested for protecting against radiation injury [6, 7] , there is only amifostine, a scavenger of reactive oxygen species (ROS) had been approved clinically as a cytoprotective adjuvant to alleviate the side effects for patients who get radiotherapy [8] .
Unfortunately, the administration of amifostine is limited due to its accumulative toxicity and side effects, including nausea, vomiting, hypotension, and allergic reactions [9] . Therefore, it is highly required to develop new agents of less or no toxicity for protecting against the potential health threats from natural, incidental, and occupational exposures to relative low dose radiations.
Nicaraven (1,2-bis (nicotinamido)-propane), synthesized chemical compound known as a hydroxyl radical-specific scavenger [10] , had previously been found to amend the survival of mice exposed to a lethal dose of γ-ray [11] , and to protect against radiationinduced cell death [12, 13] . We have recently demonstrated that the administration of nicaraven to mice soon after the exposure to a high dose of γ-ray attenuates the radiationinduced injury of hematopoietic stem/progenitor cells, via reduction of DNA damage of cells and inhibition of inflammation [14] . Taking the safety profile of nicaraven and the potential long-term healthy risk of occupational radiation exposures in consideration [2, 15] , it will be so interesting to confirm the prophylactic effect of nicaraven on radiationinduced injury, especially on these immature stem/progenitor cells after the exposure to relatively lower dose.
By daily exposure of healthy adult mice to 50 mGy γ-ray for 30 days (cumulative dose of 1.5 Gy), we investigated the prophylactic effect of administration of nicaraven against radiation-induced injury in hematopoietic stem/progenitor cells, and further to understand the relevant mechanisms.
Materials and Methods

Animals
We used 8-to 12-week-old male C57BL/6 mice (SLC, Japan) for the present study.
All experiments were approved by the Institutional Animal Care and Use Committee of Nagasaki University (No. 1108120943), and the animal procedures were performed in accordance with institutional and national guidelines.
Radiation exposure and nicaraven administration
Whole-body radiation was done by exposing the mice to γ-rays with a 137 Cs source in PS-3100SB γ-ray irradiation system (Pony Industry Co., Ltd. Osaka, Japan) [16] . To explore the effect and relevant mechanisms of nicaraven for protecting radiation-induced injury in hematopoietic stem/progenitor cells, mice were daily exposed to 50 mGy γ-rays for 30 days in sequences (cumulative dose of 1.5 Gy). Intraperitoneal injection with 100 mg/kg nicaraven [14] (Nicaraven group, n=6) or saline only (Placebo group, n=6) was done within 30 minutes before each exposure. Mice were victimized 24 hours after the last exposure, and samples of blood and bone marrow cells were collected for the subsequent experiments.
Measurements of stem cells in the peripheral blood and bone marrow
Samples of heparinized peripheral blood were collected, and the number of mononuclear cells in the blood was counted using a NucleoCounter (Chemotetec A/S, Denmark). To measure the c-kit-positive (c-kit + ) stem/progenitor cells, we isolated the nucleated cells from the peripheral blood by density gradient centrifugation [17] , and then labeled with a PE-conjugated anti-mouse CD117 (c-kit) antibody (eBioscience) for 30 minutes. Respective isotype control was used as a negative control. After washing, quantitative flow cytometry was performed using a FACSCalibur (Becton Dickinson) [17] .
We analyzed the acquired data using Cell Quest software (Becton Dickinson).
Bone marrow cells were collected from the femur and tibia, and the mononuclear cells were isolated by density gradient centrifugation. The c-kit + cells in the collected bone marrow mononuclear cells were measured as described above.
Colony-forming assay
To evaluate the function of stem/progenitor cells from peripheral blood and bone marrow, a colony-forming assay was performed by using mouse methylcellulose complete medium, according to the manufacturer's instructions (R&D System). Briefly, 1x10 5 peripheral nucleated cells or 3x10 4 bone marrow mononuclear cells were mixed well with 1 ml of medium, plated in 3-cm culture dishes, and then incubated at 37°C in a 5% CO2
incubator. The formation of colonies was observed under a microscopy, and the number of colonies was counted after 9 days (for bone marrow mononuclear cells) or 12 days (for peripheral blood nucleated cells) of incubation. The average number of colonies from duplicated assays was used for the statistical analyses.
Purification of c-kit + stem/progenitor cells
The c-kit + stem/progenitor cells were purified by using the magnetic cell sorting system (autoMACS, Miltenyi Biotec, Auburn, CA). Briefly, freshly collected bone marrow mononuclear cells were incubated with microbeads-conjugated anti-mouse CD117 (c-kit) antibody (Miltenyi Biotec) for 30 minutes. After washing, c-kit + cells were separated by passing a MACS column. The purity of the c-kit + cells collected by the autoMACS was about 90%, and the viability was more than 99%.
Detection of intracellular ROS
To elucidate the relevant mechanism, we measured the intracellular ROS level based on the oxidation of 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA, Molecular Probes Inc.) to form the fluorescent compound 2',7'-dichlorofluorescein (DCF), as described previously [16, 18] . Briefly, freshly separated c-kit + cells and c-kit-negative cells were seeded in 96-well culture plates (1x10 4 cells/100 μl/well) and incubated at 37°C in a 5% CO2 incubator for 24 hrs. Cells were then loaded with 10 µM CM-H2DCFDA at 37°C for 30 minutes. After the cells were washed, the fluorescence intensities of the wells were measured using the (ARVO X3 plate reader, Perkin Elmer).
Mouse Molecular Toxicology Pathway Finder RT2 Profiler PCR array
To compare the gene expression, RNA was isolated from pelleted c-kit + cells by using RNeasy Mini Kit and RNAse free DNase (Qiagen, Hilden, Germany). The concentration of RNA was determined using Nano Drop (Thermo Scientific, Wilmington, DE, USA), and 1 mg of RNA was used to generate cDNA using RT2 First Strand Kit (SABiosciences, a Qiagen Company). Mouse Molecular Toxicology Pathway Finder RT2
Profiler PCR array was done according to the manufacturer's instructions (SABiosciences). This PCR array profiled the expression of 370 genes representative of the 13 biological pathways involved in response to toxic drugs (Supporting Table 1 ) and exhibited good reproducibility of data [19] . The fold change of expression was calculated using SABiosciences' web-based data analysis program. Results represent the mean of four independent samples from nicaraven and placebo.
Statistical analyses
Data were represented as means ± SD. The statistical significance was determined by one-way analysis of variance (ANOVA) followed by post hoc test (Dr. SPSS II, p<0.05; Fig 2A) . However, the percentage of c-kit + cells in the nicaraven-treated mice were still measured as almost 55% of the non-irradiated healthy mice (1.9±0.1% vs.
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3.7±0.6%, p<0.001, Fig 2B) , although it was higher than that of in placebo treatment (1.4±0.2%, p<0.01, Fig 2B) .
Nicaraven enhanced the function of hematopoietic stem/progenitor cells
The functional assessment of hematopoietic stem/progenitor cells was done by colony-forming assay in vitro. The formation of colonies was also clearly detectable within 12 days from peripheral blood nucleated cells. By quantitatively counting, we found that the total number of colonies formed from peripheral blood nucleated cells was higher in the Nicaraven group than Placebo group (8.0±2.1 vs. 5.0±1.0, p<0.05; Fig 3A) .
The potency of colonies formation from peripheral blood nucleated cells of the nicaraventreated mice was kept almost the same as that of the non-irradiated healthy mice (7.3±1.2, p=0.52; Fig 3A) The formation of different types of colonies was obviously observed from bone marrow mononuclear cells after 9 days of culture. Although we did not measure the overall size, colonies was bigger in size in the Nicaraven group than of Placebo group.
Also, the total number of colonies resulting from bone marrow mononuclear cells was higher in the Nicaraven group than of Placebo group (75.8±2.7 vs. 52.2±6.0, p<0.001; Fig   3B) . However, the size and number of colonies resulting from the nicaraven-treated mice were quite similar as that of the non-irradiated healthy mice (81.8±6.6, p=0.08; Fig 3B) .
Nicaraven diminished slightly the levels of intracellular ROS
As nicaraven is well recognized as a hydroxyl radical-specific scavenger, we measured the level of intracellular ROS in purified c-kit + cells. Unexpectedly, the intracellular ROS levels in both of c-kit + stem/progenitor cells and c-kit-negative matured bone marrow mononuclear cells were measured very similar among groups, although the ROS level was slightly decreased by nicaraven treatment (Fig 4) .
Complex mechanisms involved in the protective effect of nicaraven to radiation injury
We used a Mouse Molecular Toxicology Pathway Finder RT2 Profiler PCR array to screen the gene expression changes. Among the total of 370 genes included in the array, 208 genes were detected to be up-or down-regulated over two-fold by the nicaraven administration in comparison with placebo treatment (Supporting Table) . The top 20 genes were listed up in tables ( 
Discussion
In this study, we have demonstrated that the administration of nicaraven can effectively mitigate the damage of hematopoietic stem/progenitor cells in mice exposed to successive relatively low dose of γ-ray (daily 50 mGy for 30 days). We have further found that the protective effect of nicaraven against radiation-induced injury to hematopoietic stem/progenitor cells likely associated with complex mechanisms included the inhibition of inflammation, immunomodulation and enhancement of DNA repair, rather than a simple radical scavenger reducing ROS.
A high dose ionizing radiation can directly lead to DNA double-strand break to kill the cells. It has also generally accepted that the exposure to even relative low dose of radiation may trigger the generation of ROS, which indirectly induce DNA damage and genomic instability [20] . Therefore, quickly scavenging the ROS by radical scavengers was considered as one of the effective approach for attenuating radiation-induced injury, especially that occupationally exposed to a relatively low dose radiation. Our study showed that nicaraven has a prophylactic effect on protecting c-kit + hematopoietic stem/progenitor cells against radiation injury in mice exposed to a relatively low dose radiation, although the peripheral blood nucleated cells and the percentage of c-kit + cells in bone marrow in mice received nicaraven treatment was not recovered to the levels of healthy mice.
On the mechanism, agreed well with the result of recent study in mice received high dose radiation [14] , surprisingly, the ROS level was only slightly decreased in these purified c-kit + stem/progenitor cells from mice received nicaraven when compared to those received placebo treatment. This again suggests that nicaraven protection against radiation injury seems to be associated with other mechanism rather than as simple as a radical scavenger. To further understand the potential mechanisms of the protective effect of nicaraven against radiation injury, we purified c-kit + stem/progenitor cells from mice Within these genes that associated with DNA damage repair ( Supporting Fig 1) , Fig 2) , including BCL2L1, BID and BAD that required for radiation-induced apoptosis [24] . It is known that the defect of apoptosis cause genomic instability [25, 26] . Also, some DNA repair molecules induce apoptosis in response to DNA lesions, these genes associated with apoptosis and DNA repair work together to create a complex biological network for maintaining genomic stability [27] . In other words, nicaraven treatment not only reduces cell death, but also helps to commit these c-kit + stem/progenitor cells with DNA damage into apoptosis. However, many necrotic genes were down-regulated by nicaraven treatment (Supporting Fig 3) .
Nicaraven treatment decreased the expressions of many genes associated with inflammatory response (Supporting Fig 4) This study has some limitations. The first, although complex mechanisms, including DNA repair, inflammatory response, immunomodulation, and energy supply were likely involved in nicaraven for protection against radiation injury, further study will be needed to identify the precise mechanism. The second, we only measured the percentages of c-kit + cells within bone marrow mononuclear cells and peripheral blood nucleated cells. However, it is still unclear whether the protective effect of nicaraven will be varied among different subtypes of stem/progenitor cells, such as the rare population of long-term hematopoietic stem cells (Lin-/Sca1+/c-Kit+, LSK cells). Otherwise, it is also important to compare the protective effect against radiation injury and the side effect of nicaraven with other drugs, including amifostine that is already approved for clinical application [8] .
In summary, we have confirmed that the prophylactic effect of nicaraven on protecting c-kit + hematopoietic stem/progenitor cells against radiation injury in mice exposed daily to 50 mGy γ-ray for 30 days (cumulative dose of 1.5 Gy). Although the complex molecular mechanism was not completely understood, the excellent safety profile of nicaraven provides potential possibility as prophylactic treatment for protecting against radiation injury, especially for those whom occupationally exposed to relatively low dose radiation.
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